Staff Reports
An Associated Press investigation this week pulled back the curtain on a troubling choice by the Drug Enforcement Administration in New Mexico: agents watched shipments of fake pills laced with fentanyl move into communities instead of seizing them immediately. The AP reviewed internal DEA records and a 66-page report that show agents counted deliveries — including one drop of 74,000 pills — while building long-term cases. That is the hard news. Everything else is the argument about whether this was brave strategy or reckless endangerment.
What the AP uncovered: pills counted, not stopped
The AP’s reporting makes plain that DEA surveillance teams in Albuquerque tracked multiple deliveries of counterfeit pills containing fentanyl and let them pass so they could trace suppliers. According to the internal files the AP reviewed, agents watched a June operation where 74,000 pills were exchanged. Whistleblower accounts say the practice allowed many more pills into the streets — roughly 1.8 million, by one estimate. That is not a hypothetical. Those are pills that could kill people if misused.
The whistleblower says he was punished
DEA Special Agent David Howell blew the whistle. He told the AP that he warned supervisors this tactic would poison communities and resisted decisions to stand down. Instead of being heard, he says he was pushed to desk duty, had performance marks lowered, and was barred from testifying in court. If true, that looks less like disciplined oversight and more like career punishment for raising a public-safety alarm.
Agency defense and the policy puzzle
DEA spokesperson Amanda Wozniak says the investigative choices were lawful and “reasonable.” The Justice Department’s Office of Professional Responsibility reviewed the matter and reached a similar conclusion. But law and policy are not the same as wisdom. Controlled deliveries are an old tool, yet fentanyl is not an old problem — it kills fast and in tiny doses. The Department rewrote internal guidance recently to give more discretion, but discretion is dangerous without oversight. Letting lethal pills flow to score a big bust looks like a poker hand played with other people’s lives on the table.
What should happen next
Whistleblower advocates and oversight groups are asking Congress and inspectors to dig into the files the AP exposed. That is the right call. The public deserves to know who signed off on letting fentanyl pills hit neighborhoods and why prosecutors later hailed a massive seizure as a success if earlier shipments were allowed through. Drug enforcement needs results, yes — but not at the cost of turning communities into crime‑scene testing grounds. If the DEA expects public trust, it should welcome a full, transparent review and hold leaders accountable for choices that risked lives.
